The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication

Posaconazole (PCZ) is a clinically approved drug used predominantly for prophylaxis and salvage therapy of fungal infections. Here, we report its previously undescribed anti-human cytomegalovirus (HCMV) activity. By using antiviral assays, we demonstrated that PCZ, along with other azolic antifungal...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Mercorelli, Beatrice, Luganini, Anna, Celegato, Marta, Palù, Giorgio, Gribaudo, Giorgio, Lepesheva, Galina I., Loregian, Arianna
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2020
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7508619/
https://ncbi.nlm.nih.gov/pubmed/32690644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00056-20
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares